Formestane

This publication has 58 references indexed in Scilit:

• The clinical and endocrine effects of 4-hydroxyandrostenedione alone and in combination with goserelin in premenopausal women with advanced breast cancer
  British Journal of Cancer, 1990
• The inhibition of human prostatic aromatase activity by imidazole drugs including ketoconazole and 4-hydroxyandrostenedione
  Biochemical Pharmacology, 1990
• Quantitative determination of 4-hydroxy-4-androstene-3, 17-dione (4-oha), a potent aromatase inhibitor, in human plasma, using isotope dilution mass spectrometry
  The Journal of Steroid Biochemistry and Molecular Biology, 1989
• DOSE-RELATED ENDOCRINE EFFECTS AND PHARMACOKINETICS OF ORAL AND INTRAMUSCULAR 4-HYDROXYANDROSTENEDIONE IN POSTMENOPAUSAL BREAST-CANCER PATIENTS
  1989
• 4-Hydroxyandrostenedione treatment for postmenopausal patients with advanced breast cancer
  Steroids, 1987
• Antibodies to 4-hydroxyandrostenedione ? a new anti-breast cancer agent suitable for use in a radioimmunoassay
  Cancer Chemotherapy and Pharmacology, 1987
• RESPONSE OF NITROSOMETHYLUREA-INDUCED RAT MAMMARY-TUMOR TO ENDOCRINE THERAPY AND COMPARISON WITH CLINICAL-RESPONSE
  1986
• EFFECTS OF AROMATASE INHIBITORS, AMINOGLUTETHIMIDE, AND 4-HYDROXYANDROSTENEDIONE ON CYCLIC RATS AND RATS WITH 7,12-DIMETHYLBENZ(A)ANTHRACENE-INDUCED MAMMARY-TUMORS
  1985
• Comparative studies of aromatase inhibitors in relation to the significance of estrogen synthesis in human mammary tumors.
  1982
• Failure of human benign prostatic hyperplasia to aromatise testosterone
  The Journal of Steroid Biochemistry and Molecular Biology, 1982